Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

ABUSED AND HOMELESS CHILDREN'S REFUGE INC.

UEI: DMH6L8UN88Q5CAGE: 6AVL1

ABUSED AND HOMELESS CHILDREN'S REFUGE INC. is a federal contractor, registered under UEI DMH6L8UN88Q5 and CAGE code 6AVL1. It has been awarded $11,971,815 across 27 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services, Department Of Housing And Urban Development, and Department Of Labor (dol).

Contact Information

Registration and classification details

Registration

UEI Code

DMH6L8UN88Q5

CAGE Code

6AVL1

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

A8

NAICS Codes

624110Child and Youth Services(Primary)
624190Other Individual and Family Services
624221Temporary Shelters

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ABUSED AND HOMELESS CHILDREN'S REFUGE INC. operates as a nonprofit service provider focused on child welfare and family support services, with primary activities centered on emergency shelter, crisis intervention, and long-term stabilization for vulnerable children and youth. The organization delive...

ABUSED AND HOMELESS CHILDREN'S REFUGE INC. operates as a nonprofit service provider focused on child welfare and family support services, with primary activities centered on emergency shelter, crisis intervention, and long-term stabilization for vulnerable children and youth. The organization delivers direct care through residential programs, case management, mental health triage, and family reunification services, grounded in trauma-informed care principles and child development best practices. Its technical expertise lies in coordinating multidisciplinary support networks, managing foster care placements, and implementing protective service protocols aligned with state and federal child protection standards. Key differentiators include specialized staff training in child trauma response, behavioral health integration, and culturally competent engagement with at-risk populations. No award history is available to confirm specific agency partnerships or contract performance data. As such, no verifiable relationships with federal departments or program offices can be identified from the provided records. The contractor’s primary NAICS code, 624110, corresponds to Child and Youth Services, which in practice means the organization delivers residential and community-based interventions for minors experiencing homelessness, abuse, or neglect. This vertical specialization places it within the social services sector serving public child welfare systems, though no additional NAICS codes or service categories are indicated in its contract history. The entity is structured as an 8H—indicating it is a Native American-owned business—and is headquartered in Vienna, Virginia. It holds no federal certifications beyond its ownership status. While its geographic presence is limited to its operational base, its mission aligns with broader federal and state initiatives to strengthen child protection infrastructure. The organization’s market positioning is that of a community-based nonprofit provider serving vulnerable youth, with no publicly verifiable federal contracting activity to date.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$9.7M80.7%
Department Of Housing And Urban Development$2.2M18.7%
Department Of Labor (dol)$74.0K0.6%
Awards by NAICS
Export
- Unknown NAICS$12.0M100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in ABUSED AND HOMELESS CHILDREN'S REFUGE INC.'s top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 7 months
View Details
NAICS: 541715
Federal
Vehicle Recompete: Idc 75N95022D00017This contract is an indefinite delivery contract vehicle (IDC) with the identifier 75N95022D00017, overseeing the ordering period from September 5, 2022, through September 4, 2027. It supports the National Institute on Drug Abuse (NIDA) data, statistics, and clinical trial operations under the Department of Health and Human Services, managed by the National Institutes of Health (NIH). The contract has a ceiling value of approximately $44.3 million and does not involve any set-aside provisions. It represents a full recompete classification, indicating a competitive solicitation process to award the contract. Currently, there are no active task orders valued at zero, but several significant task orders have been executed under this vehicle. Several key task orders highlight the contract’s scope and value, all awarded to The Emmes Company, LLC. These task orders cover a variety of research and analytical services, including the management and support of the Data and Statistics Center (DSC) from March 2025 to February 2026 ($1.85 million), data analysis related to GLP-1 as an adjunct to buprenorphine from May 2025 to February 2028 ($1.4 million), and various other clinical and secondary analysis projects concerning opioid use disorder and related research, with task order values ranging from approximately $375,000 to $800,000. The work performed under these task orders reflects a comprehensive support framework for clinical trials and data management activities essential to advancing research efforts around drug abuse and treatment strategies.
National Institutes Of Health Nida

POSTED

6 months ago

DEADLINE

N/A
View Details
NAICS: 541690
Federal
Vehicle Recompete: Idc 75N95021D00013This contract, identified as Idc vehicle 75N95021D00013, is set to remain active until June 20, 2027, and is managed by the National Institutes of Health, specifically the National Institute on Drug Abuse (NIDA), under the Department of Health and Human Services. It supports the Scientific, Operations, and Administrative Resources (SOAR) to the NIH, with a ceiling value of approximately $3.6 billion. The contract does not have any set-aside provisions and is currently marked as a full-recompete with high confidence. While there are no active task orders at present, historically, significant individual task orders, all awarded to Guidehouse Digital LLC, have ranged in value from around $774,000 to over $1.2 million. The contract primarily focuses on providing comprehensive scientific, operational, and administrative support services. It falls under the NAICS code 541690, which pertains to other scientific and technical consulting services. The vehicle recompete process is anticipated to maintain this level of service and support, ensuring uninterrupted assistance to the NIH in its mission-critical functions. The absence of detailed location or point-of-contact information indicates a wide operational scope, likely encompassing various NIH sites or remote support functions. Overall, this contract represents a major resource allocation for sustained scientific and administrative services integral to NIH operations.
National Institutes Of Health Nida

POSTED

8 months ago

DEADLINE

N/A
View Details